Insulin Site Rotation and Glucometer QA Failures
Summary
The facility failed to ensure professional standards were met in insulin administration by not rotating subcutaneous injection sites for two sampled residents. One resident was admitted with type 2 DM, diabetic chronic kidney disease, and long-term insulin use, and the record showed repeated insulin lispro injections in the same abdominal areas, including the right lower quadrant and left lower quadrant on multiple administrations. RN 1 stated there were multiple instances where licensed staff did not rotate the insulin administration sites, and stated the facility’s electronic record showed where the last insulin dose had been given. The DON stated the insulin sites should have been rotated to prevent skin integrity issues such as bruising and scar tissue buildup, which she identified as lipodystrophy. A second resident was admitted with long-term insulin use, and the record showed an order for Novolin R insulin given subcutaneously before meals based on sliding scale blood sugars. The facility’s insulin administration policy stated injection sites should be rotated, preferably within the same general area, and the insulin manufacturer instructions also directed that injection sites be changed within the chosen area for each dose. The report identified that the licensed staff did not follow the facility’s insulin administration procedure for these residents. The facility also failed to perform glucometer control solution testing according to the user guide for one resident observed during a blood sugar check. During observation, an LVN obtained a blood glucose reading of 304 and administered Humalog insulin. Review of the glucometer QA logs showed control testing entries signed by an LVN on multiple dates, but the corresponding high and low results were not documented on the logs for some of those dates. LVN 3 stated he could not find the control results to confirm the documented QA log entries and stated he did not do the control solution testing on two of the dates. During demonstration, LVN 3 performed control testing by applying solution directly from the bottle to the test strip, which differed from the user guide instructions requiring the solution to be placed on a clean, dry, non-absorbent surface before touching the strip to the drop. The DON stated the control solution testing is done daily to ensure the meter is functioning properly and accurately.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.